Change Healthcare has added AI capabilities to its CareSelect Imaging clinical decision support (CDS) solution.
The move is designed to improve the quality of patient care and help providers comply with the Protecting Access to Medicare Act of 2014 (PAMA), which will require physicians to consult appropriate use criteria through a CDS system before placing advanced imaging orders beginning on Jan. 1, 2020.
“Bringing Change Healthcare AI to CareSelect Imaging helps providers ensure they’re delivering the highest quality, most appropriate care, while reducing their administrative and regulatory burdens through advanced automation,” Michael Mardini, CEO of National Decision Support Company, a Change Healthcare company, said in a prepared statement. “This is a perfect example of how strategic applications of AI will continue to improve healthcare processes and benefit all stakeholders.”
“We’re committed to optimizing clinical, administrative, and regulatory processes by infusing Change Healthcare AI into existing workflows across our large installed base of payers and providers,” Nick Giannasi, PhD, executive vice president and chief AI officer for Change Healthcare, said in the same statement.
Prior coverage related to PAMA, all from Radiology Business, can be read here, here and here.
Michael has more than 16 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.